Status:
UNKNOWN
Nabothian Cyst Protects or Facilitates Against Cervical Cancer
Lead Sponsor:
Haseki Training and Research Hospital
Conditions:
HPV Infection
Nabothian Cyst
Eligibility:
FEMALE
25-65 years
Brief Summary
Aim of the study to asses the realition between HPV infection, Nabothian Cyst and Cervical Intraepithelial lesions or Cervical Cancer
Detailed Description
Nabothian cysts are one of the common gynecological pathologies. They rarely have clinical significance. Transvaginal ultrasonography and magnetic resonance imaging are the most useful imaging methods...
Eligibility Criteria
Inclusion
- To have Naboth cyst and/or HPV positivity Must be willing and able to provide informed consent Comply with the study protocol Between 25-65 age range
Exclusion
- To Refuse participate in our research The age under 25 and over 65 Ovarian, endometrial and vulvar malignancies Without both Naboth's cyst and HPV positivity To have LEEP/Cervical Conization before History of Cervical Dysplasia
Key Trial Info
Start Date :
July 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
1005 Patients enrolled
Trial Details
Trial ID
NCT04488991
Start Date
July 23 2020
End Date
March 1 2021
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cihan Comba
Istanbul, Sultangazi, Turkey (Türkiye), 34265